Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04309786 · ClinicalTrials.gov registry record
Somatization, Anxiety, and Disordered Sleep in Pediatric Eosinophilic Esophagitis
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 98
- Enrollment target
NCT04309786: Completed study, sponsored by University of California, San Diego.
NCT04309786 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 98 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04309786 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
Study Summary
Eosinophilic esophagitis
Primary Outcome
Our researchers will be using CSSI-Child Somatic Symptoms Inventory to measure the severity of bothersome somatic symptoms experienced in our EoE children and adolescents. Respondents are asked to rate the extent to which the child was bothered by each of the nonspecific somatic symptoms listed. Total scores are computed by summing the ratings for each item. Higher scores indicate greater somatic distress.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2019-04-11 |
| Est. Completion | 2021-04-26 |
What the finished NCT04309786 record still lists
NCT04309786 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 98 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04309786 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04309786 about?
NCT04309786 is a clinical study titled "Somatization, Anxiety, and Disordered Sleep in Pediatric Eosinophilic Esophagitis". Eosinophilic esophagitis
What is the current status of trial NCT04309786?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2019-04-11. Estimated completion is 2021-04-26.
Who is sponsoring clinical trial NCT04309786?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI